Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast.

Green AR, Krivinskas S, Young P, Rakha EA, Paish EC, Powe DG, Ellis IO.

Breast Cancer Res Treat. 2009 Jan;113(1):59-66. doi: 10.1007/s10549-008-9905-8. Epub 2008 Jan 23.

PMID:
18213475
2.

The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.

Green AR, Young P, Krivinskas S, Rakha EA, Claire Paish E, Powe DG, Ellis IO.

Histopathology. 2009 Mar;54(4):419-27. doi: 10.1111/j.1365-2559.2009.03233.x.

PMID:
19309393
3.

Loss of chromosome 16q in lobular carcinoma in situ.

Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung BM, Waldman FM.

Hum Pathol. 2001 Mar;32(3):292-6.

PMID:
11274638
4.
5.

Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.

Zou D, Yoon HS, Perez D, Weeks RJ, Guilford P, Humar B.

J Pathol. 2009 Jun;218(2):265-72. doi: 10.1002/path.2541.

PMID:
19294736
7.
8.

Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1.

Rakha EA, Pinder SE, Paish CE, Ellis IO.

Br J Cancer. 2004 Oct 18;91(8):1591-6.

9.

E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.

Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ.

Br J Cancer. 1997;76(9):1131-3.

10.

E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.

Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL.

Mod Pathol. 2005 Jun;18(6):741-51.

11.

Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma.

Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM.

Cancer. 2004 Jun 15;100(12):2562-72.

12.

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.

Buerger H, Simon R, Schäfer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Böcker W.

Mol Pathol. 2000 Jun;53(3):118-21.

13.

Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.

van Wezel T, Lombaerts M, van Roon EH, Philippo K, Baelde HJ, Szuhai K, Cornelisse CJ, Cleton-Jansen AM.

Breast Cancer Res. 2005;7(6):R998-1004. Epub 2005 Oct 18.

14.

Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer.

Hungermann D, Schmidt H, Natrajan R, Tidow N, Poos K, Reis-Filho JS, Brandt B, Buerger H, Korsching E.

J Pathol. 2011 Aug;224(4):517-28. doi: 10.1002/path.2938. Epub 2011 Jun 27.

PMID:
21706489
15.

Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast.

Mastracci TL, Shadeo A, Colby SM, Tuck AB, O'Malley FP, Bull SB, Lam WL, Andrulis IL.

Genes Chromosomes Cancer. 2006 Nov;45(11):1007-17.

PMID:
16897748
16.

Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.

Giricz O, Reynolds PA, Ramnauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro N, Fineberg S, Kenny PA, Loudig O.

J Pathol. 2012 Jan;226(1):108-19. doi: 10.1002/path.2978. Epub 2011 Sep 26.

PMID:
21953071
17.

Biomarker profile and genetic abnormalities in lobular carcinoma in situ.

Mohsin SK, O'Connell P, Allred DC, Libby AL.

Breast Cancer Res Treat. 2005 Apr;90(3):249-56.

PMID:
15830138
18.
19.

Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.

Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, Hajduch M, Murray P, Kolar Z.

BMC Cancer. 2007 Mar 27;7:55.

20.

Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.

Jacobs TW, Pliss N, Kouria G, Schnitt SJ.

Am J Surg Pathol. 2001 Feb;25(2):229-36.

PMID:
11176072

Supplemental Content

Support Center